LOM
SLXP

Loeb Offshore Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Loeb Offshore Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4.6M Sell
40,000
-39,062
-49% -$4.73M 0.84% 39
2014
Q3 		$12.4M Buy
+79,062
New +$11.5M 1.81% 13
2013
Q4 		– Sell
-3,553
Closed -$238K – 270
2013
Q3 		$238K Buy
+3,553
New +$245K 0.07% 177

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loeb Offshore Management's SLXP Position: Q4 2014 in Review

Loeb Offshore Management reduced its SALIX PHARMACEUTICALS LTD DEL (SLXP) stake by 49% in Q4 2014, selling an estimated $4.73M and leaving 40,000 shares worth $4.6M. The position accounts for 0.84% of the portfolio, ranked #39.

Loeb Offshore Management first reported a position in SLXP in Q3 2013 and has held it in 3 quarters since. The position peaked at $12.4M in Q3 2014. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • Loeb Offshore Management held 40,000 shares of SALIX PHARMACEUTICALS LTD DEL worth $4.6M as of Q4 2014.
  • Loeb Offshore Management sold 39,062 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $4.73M.
  • SALIX PHARMACEUTICALS LTD DEL made up 0.84% of Loeb Offshore Management's portfolio in Q4 2014, its #39 holding.
  • Loeb Offshore Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and has held it in 3 quarters since.
  • Loeb Offshore Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $12.4M in Q3 2014.
  • 346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on Loeb Offshore Management's 13F filing for Q4 2014, filed 17 Feb 2015.